The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Degradation of MyoD Mediated by the SCF (MAFbx) Ubiquitin Ligase
Open accessAbstract
MyoD controls myoblast identity and differentiation and is required for myogenic stem cell function in adult skeletal muscle. MyoD is degraded by the ubiquitin-proteasome pathway mediated by different E3 ubiquitin ligases not identified as yet. Here we report that MyoD interacts with Atrogin-1/MAFbx (MAFbx), a striated muscle-specific E3 ubiquitin ligase dramatically up-regulated in atrophying muscle. A core LXXLL motif sequence in MyoD is necessary for binding to MAFbx. MAFbx associates with MyoD through an inverted LXXLL motif located in a series of helical leucine-charged residue-rich domains. Mutation in the LXXLL core motif represses ubiquitination and degradation of MyoD induced by MAFbx. Overexpression of MAFbx suppresses MyoD-induced differentiation and inhibits myotube formation. Finally the purified recombinant SCF(MAFbx) complex (SCF, Skp1, Cdc53/Cullin 1, F-box protein) mediated MyoD ubiquitination in vitro in a lysine-dependent pathway. Mutation of the lysine 133 in MyoD prevented its ubiquitination by the recombinant SCF(MAFbx) complex. These observations thus demonstrated that MAFbx functions in ubiquitinating MyoD via a sequence found in transcriptional coactivators. These transcriptional coactivators mediate the binding to liganded nuclear receptors. We also identified a novel protein-protein interaction module not yet identified in F-box proteins. MAFbx may play an important role in the course of muscle differentiation by determining the abundance of MyoD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hershko, A., & Ciechanover, A. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.425 · Cited by 8,840
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Identification of ubiquitin ligases required for skeletal muscle atrophy.
Bodine, S. C., Latres, E., Baumhueter, S., Lai, V. K.-M., Nunez, L., Clarke, B. A., Poueymirou, W. T., Panaro, F. J., Na, E., Dharmarajan, K., et al. (2001) · Science · doi:10.1126/science.1065874 · Cited by 3,521
A signature motif in transcriptional co-activators mediates binding to nuclear receptors
Heery, D. M., Kalkhoven, E., Hoare, S., & Parker, M. G. (1997) · Nature · doi:10.1038/42750 · Cited by 2,128
Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy
Gomes, M. D., Lecker, S. H., Jagoe, R. T., Navon, A., & Goldberg, A. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251541198 · Cited by 1,774
Ohh, M., Park, C. W., Ivan, M., Hoffman, M. A., Kim, T.-Y., Huang, L. E., Pavletich, N., Chau, V., & Kaelin, W. G. (2000) · Nature Cell Biology · doi:10.1038/35017054 · Cited by 1,577
The ubiquitin-proteasome pathway: on protein death and cell life
Ciechanover, A. (1998) · The EMBO Journal · doi:10.1093/emboj/17.24.7151 · Cited by 1,426
Skowyra, D., Craig, K. L., Tyers, M., Elledge, S. J., & Harper, J. W. (1997) · Cell · doi:10.1016/s0092-8674(00)80403-1 · Cited by 1,224
The MyoD family and myogenesis: Redundancy, networks, and thresholds
Weintraub, H. (1993) · Cell · doi:10.1016/0092-8674(93)90610-3 · Cited by 1,057
MyoD is required for myogenic stem cell function in adult skeletal muscle
Megeney, L. A., Kablar, B., Garrett, K., Anderson, J. E., & Rudnicki, M. A. (1996) · Genes & Development · doi:10.1101/gad.10.10.1173 · Cited by 724
Olson, E. N., & Klein, W. H. (1994) · Genes & Development · doi:10.1101/gad.8.1.1 · Cited by 690
Myogenic specification of side population cells in skeletal muscle
Asakura, A., Seale, P., Girgis-Gabardo, A., & Rudnicki, M. A. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200202092 · Cited by 679
Huss, J. M., Kopp, R. P., & Kelly, D. P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206324200 · Cited by 479
Positive autoregulation of the myogenic determination gene MyoD1
Thayer, M. J., Tapscott, S. J., Davis, R. L., Wright, W. E., Lassar, A. B., & Weintraub, H. (1989) · Cell · doi:10.1016/0092-8674(89)90838-6 · Cited by 471
Control of muscle development by dueling HATs and HDACs
McKinsey, T. A., Zhang, C. L., & Olson, E. N. (2001) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(00)00224-0 · Cited by 414
What do we really know about the ubiquitin-proteasome pathway in muscle atrophy?
Jagoe, R. T., & Goldberg, A. L. (2001) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/00075197-200105000-00003 · Cited by 399
Satellite Cell Proliferative Compartments in Growing Skeletal Muscles
Schultz, E. (1996) · Developmental Biology · doi:10.1006/dbio.1996.0097 · Cited by 393
Nuclear Hormone Receptor Coregulators In Action: Diversity For Shared Tasks
Robyr, D. (2000) · Molecular Endocrinology · doi:10.1210/me.14.3.329 · Cited by 381
Identification of a family of human F-box proteins
Cenciarelli, C., Chiaur, D. S., Guardavaccaro, D., Parks, W., Vidal, M., & Pagano, M. (1999) · Current Biology · doi:10.1016/s0960-9822(00)80020-2 · Cited by 367
A family of mammalian F-box proteins
Winston, J. T., Koepp, D. M., Zhu, C., Elledge, S. J., & Harper, J. W. (1999) · Current Biology · doi:10.1016/s0960-9822(00)80021-4 · Cited by 357
Acetylation of MyoD Directed by PCAF Is Necessary for the Execution of the Muscle Program
Sartorelli, V., Puri, P. L., Hamamori, Y., Ogryzko, V., Chung, G., Nakatani, Y., Wang, J. Y. J., & Kedes, L. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80383-4 · Cited by 356
E3 ubiquitin ligase that recognizes sugar chains
Yoshida, Y., Chiba, T., Tokunaga, F., Kawasaki, H., Iwai, K., Suzuki, T., Ito, Y., Matsuoka, K., Yoshida, M., Tanaka, K., et al. (2002) · Nature · doi:10.1038/nature00890 · Cited by 350
Kitzmann, M., Carnac, G., Vandromme, M., Primig, M., Lamb, N. J. C., & Fernandez, A. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.142.6.1447 · Cited by 324
MyoD−/− Satellite Cells in Single-Fiber Culture Are Differentiation Defective and MRF4 Deficient
Cornelison, D. D. W., Olwin, B. B., Rudnicki, M. A., & Wold, B. J. (2000) · Developmental Biology · doi:10.1006/dbio.2000.9682 · Cited by 317
Ligand-independent recruitment of steroid receptor coactivators to estrogen receptor by cyclin D1
Zwijsen, R. M. L., Buckle, R. S., Hijmans, E. M., Loomans, C. J. M., & Bernards, R. (1998) · Genes & Development · doi:10.1101/gad.12.22.3488 · Cited by 305
Breitschopf, K. (1998) · The EMBO Journal · doi:10.1093/emboj/17.20.5964 · Cited by 287
Helix-loop-helix proteins as regulators of muscle-specific transcription.
Edmondson, D. G., & Olson, E. N. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53995-8 · Cited by 278
Mal, A. (2001) · The EMBO Journal · doi:10.1093/emboj/20.7.1739 · Cited by 259
Crosstalk between cell cycle regulators and the myogenic factor MyoD in skeletal myoblasts
Kitzmann, M., & Fernandez, A. (2001) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000882 · Cited by 228
Phosphorylation of Nuclear MyoD Is Required for Its Rapid Degradation
Song, A., Wang, Q., Goebl, M. G., & Harrington, M. A. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.9.4994 · Cited by 165
Heery, D. M., Hoare, S., Hussain, S., Parker, M. G., & Sheppard, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009404200 · Cited by 158
Zhang, J., Wei, Q., Zhao, X., & Paterson, B. M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.4.926 · Cited by 137
CREB-binding Protein/p300 Activates MyoD by Acetylation
Polesskaya, A., Duquet, A., Naguibneva, I., Weise, C., Vervisch, A., Bengal, E., Hucho, F., Robin, P., & Harel‐Bellan, A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003815200 · Cited by 131
Reynaud, E. G., Pelpel, K., Guillier, M., Leibovitch, M.-P., & Leibovitch, S. A. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.11.7621 · Cited by 124
Self-citationHatoum, O. A., Gross-Mesilaty, S., Breitschopf, K., Hoffman, A., Gonen, H., Ciechanover, A. J., & Bengal, E. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.10.5670 · Cited by 124
Kitzmann, M., Vandromme, M., Schaeffer, V., Carnac, G., Labbé, J., Lamb, N. J. C., & Fernandez, A. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.4.3167 · Cited by 114
Stabilization of MyoD by Direct Binding to p57Kip2
Reynaud, E. G., Leibovitch, M.-P., Tintignac, L. A. J., Pelpel, K., Guillier, M., & Leibovitch, S. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m907412199 · Cited by 108
Self-citationZhang, J., Zhao, X., Wei, Q., & Paterson, B. M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.24.6983 · Cited by 104
The Nuclear Ubiquitin-Proteasome System Degrades MyoD
Floyd, Z. E., Trausch‐Azar, J. S., Reinstein, E., Ciechanover, A. J., & Schwartz, A. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009388200 · Cited by 75
Cyclin E–Cdk2 Phosphorylation Promotes Late G1-Phase Degradation of MyoD in Muscle Cells
Tintignac, L. A. J., Leibovitch, M.-P., Kitzmann, M., Fernandez, A., Ducommun, B., Meijer, L., & Leibovitch, S. A. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4973 · Cited by 71
Self-citationDeterminants of Nuclear and Cytoplasmic Ubiquitin-mediated Degradation of MyoD
Lingbeck, J. M., Trausch‐Azar, J. S., Ciechanover, A. J., & Schwartz, A. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208815200 · Cited by 62
Identification of Novel MyoD Gene Targets in Proliferating Myogenic Stem Cells
Wyzykowski, J. C., Winata, T. I., Mitin, N., Taparowsky, E. J., & Konieczny, S. F. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.17.6199-6208.2002 · Cited by 50
Mutant MyoD Lacking Cdc2 Phosphorylation Sites Delays M-Phase Entry
Tintignac, L. A. J., Sirri, V., Leibovitch, M.-P., Lécluse, Y., Castedo, M., Métivier, D., Kroemer, G., & Leibovitch, S. A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.4.1809-1821.2004 · Cited by 45
Self-citationCritical Role for Lysine 133 in the Nuclear Ubiquitin-mediated Degradation of MyoD
Batonnet‐Pichon, S., Leibovitch, M.-P., Tintignac, L. A. J., & Leibovitch, S. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310315200 · Cited by 28
Self-citation
Cited by
Mechanisms regulating skeletal muscle growth and atrophy
Schiaffino, S., Dyar, K. A., Ciciliot, S., Blaauw, B., & Sandri, M. (2013) · The FEBS Journal · doi:10.1111/febs.12253 · Cited by 1,492
Cellular and molecular mechanisms of muscle atrophy
Bonaldo, P., & Sandri, M. (2013) · Disease Models & Mechanisms · doi:10.1242/dmm.010389 · Cited by 1,284
Protein degradation by the ubiquitin-proteasome pathway in normal and disease states
Lecker, S. H., Goldberg, A. L., & Mitch, W. E. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006010083 · Cited by 1,234
Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1
Bodine, S. C., & Baehr, L. M. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00204.2014 · Cited by 1,113
Skeletal muscle hypertrophy and atrophy signaling pathways
Glass, D. J. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.04.018 · Cited by 1,106
Metadata
- Authors
- Tintignac, L. A., Lagirand, J., Batonnet, S., Sirri, V., Leibovitch, M. P., & Leibovitch, S. A.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2005-01
- Volume
- 280
- Issue
- 4
- Pages
- 2847-2856
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1965047073
- Cited by
- 405
- References
- 44
- FWCI
- 6.01
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.